Pfizer Inc.'s experimental drug for cancer weight loss was shown to help patients regain weight in a mid-stage study, ...

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked ...

As Eli Lilly and Novo Nordisk continue to dominate the lucrative weight-loss drug market, smaller competitors are gearing up ...

The Clinical Trials Arena team investigates assets in infectious diseases, metabolic disorders, oncology and ophthalmology.

In the United States and some countries other than Europe, Lilly owns exclusive development and commercialization rights to ...

The release of early-stage data on three oral weight loss drug candidates hints at which companies have the strongest hand, ...

Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease.

The FDA should have more big news for Vertex only a few weeks later. It expects to announce an approval decision on ...

A summer wave of cases locally and across the country may be on the decline and a vaccine targeting the latest variants is ...

And now that “cold and flu” season has become COVID-19, cold, flu and RSV season, medical experts are urging folks to head to ...

Dermavant Sciences Ltd. to Organon & Co. for $1.2 billion. The massive amount comprises an up-front $175 million payment, along with a potential $75 million regulatory milestone and up to $950 million ...

The Florida Department of Health, run by Surgeon General Dr. Joseph Ladapo, just released guidance on COVID-19 vaccines based ...